{{cartTotalQuantity}}
Menu di diagnostica molecolare
Strumenti e software
Le soluzioni di Cepheid
Accesso ai test ovunque
Utilizzo degli antibiotici
Cepheid’s Insights
Webinar
Cepheid RADAR
Support Center
Contatti
Informazioni su Cepheid
Missione e storia
Eventi
Distributori
Opportunità di sviluppo aziendale
Innovazione con Cepheid
Presentazione della moto Cepheid
Novità
La nostra leadership
Opportunità di lavoro
Team editoriale
5 minuti di lettura
7 gennaio 2026
6 minuti di lettura
2 giugno 2026
3 minuti di lettura
2 giugno 2026
6 minuti di lettura
9 settembre 2026
Articolo
Researchers analyzing multiplex gastrointestinal (GI) panel results found that multiple E. coli pathotypes were frequently detected alongside other enteric pathogens, potentially complicating data interpretation.
The findings were presented at the Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Clinical Lab Expo.
Punti chiave
Study Summary
This retrospective analysis used Truveta electronic health record data (53.757 encounters) to evaluate patients tested with multiplex GI panels in acute care settings, including emergency departments and inpatient units. Researchers identified panels using CPT and LOINC codes, then assessed the five most frequent pathogens co-detected with EPEC, EAEC, and ETEC. Co-detection was defined as two or more pathogens reported on a single panel, with prevalence calculated among patients tested for both organisms. The analysis found that E. coli pathotypes were commonly detected with viral and bacterial pathogens. This co-detection can complicate interpretation and may influence inappropriate antibiotic prescribing, especially when the pathogenic role of E. coli is unclear.
The Challenge
Multiplex GI panels can rapidly detect a broad range of organisms, but broad detection can also introduce interpretation challenges. This is especially true when organisms such as EPEC or EAEC may represent colonization rather than the primary cause of symptoms. When these findings appear alongside viral pathogens or other bacteria, clinicians may face uncertainty about which result is clinically actionable.
The Insight
"Detection alone does not always identify the causative pathogen,” said lead study author, Anita Mohandas. “When E. coli pathotypes are found alongside viral or bacterial organisms, clinical context becomes essential for determining whether treatment is warranted."
Conclusione
This study underscores a practical challenge in syndromic GI testing: more detection does not always mean clearer clinical direction. Frequent E. coli co-detections, particularly with viral pathogens, highlight the need for careful interpretation, clinician education, and panel design that prioritizes clinically actionable results.
Abbreviazioni
EPEC enteropathogenic E. coli; EAEC enteroaggregative E. coli; ETEC enterotoxigenic E. coli; DEC diarrheagenic E. coli; CPT Current Procedural Terminology; LOINC Logical Observation Identifiers Names and Codes
Vuoi saperne di più?
Authors: Anita Mohandas, MSc, MHPª; Riley Zambrano, MScª; Jordan Chase, BAª; Christophe Martinaud, MD, PhDª
ªCepheid, Sunnyvale, CA, USA
ADLM 2026. Poster A-305
Il contenuto presentato in questa pagina è destinato a scopi informativi e formativi. Sebbene sia disponibile a livello globale, può riflettere pratiche cliniche o considerazioni sul sistema sanitario specifiche di una determinata regione.
MOLTO PIÙ